ARPRIDE 150MG TABLET

About ARPRIDE 150MG TABLET

Arpride 150MG Tablet contains olaparib 150mg. It stops cancer cells from repairing their DNA, which works especially well when the cancer carries a BRCA gene change, which is why it is classed as a PARP inhibitor (targeted therapy). Specialists use it for BRCA-mutated ovarian, breast, prostate and pancreatic cancer, often as maintenance after chemotherapy. During treatment expect regular checks such as monthly blood counts for anaemia. Made by RPG Life Sciences; pack size 60 tablets. MRP Rs 11,999 as per the NPPA revision of 9 November 2026. Never start, stop or change it on your own - the oncologist or specialist decides the plan.